Page last updated: 2024-08-25

methotrexate and Neoplasm Metastasis, Unknown Primary

methotrexate has been researched along with Neoplasm Metastasis, Unknown Primary in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (25.00)	18.7374
1990's	2 (25.00)	18.2507
2000's	2 (25.00)	29.6817
2010's	2 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chao, TK; Hou, WC; Kao, CC; Lai, YJ; Li, HM; Su, HY; Yu, MH	1
El-Shaboury, H; Fasler, JJ; Guirguis, R; Joannides, AJ; Rajagopal, V	1
Abrey, LE; Begemann, M; Lassman, AB; Malkin, MG; Panageas, KS; Raizer, JJ; Shah, GD; Shah, GG	1
Davila, G; Delattre, JY; Duyckaerts, C; Lazareth, JP; Poisson, M	1
Brenin, DR; Brill, KL	1
Coit, D; Colofiore, J; Kelsen, D; Martin, DS; Sawyer, R	1
Falchuk, SC; Le Chevalier, T; Rouesse, J; Sevin, D; Spielman, M; Treat, J; Tremblay, C; Woolley, PV	1
Horn, Y; Walach, N	1

Reviews

2 review(s) available for methotrexate and Neoplasm Metastasis, Unknown Primary

Article	Year
Diffuse primary leptomeningeal gliomatosis. Journal of neuro-oncology, 1993, Volume: 15, Issue:1 Topics: Adult; Astrocytoma; Brain Neoplasms; Cranial Irradiation; Hippocampus; Humans; Injections, Spinal; Male; Meningeal Neoplasms; Methotrexate; Neoplasms, Unknown Primary	1993
Occult breast cancer and axillary mass. Current treatment options in oncology, 2001, Volume: 2, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Cisplatin; Decision Trees; Female; Fluorouracil; Humans; Mastectomy; Methotrexate; Neoplasms, Unknown Primary; Practice Guidelines as Topic	2001

Trials

2 trial(s) available for methotrexate and Neoplasm Metastasis, Unknown Primary

Article	Year
Systemic high-dose intravenous methotrexate for central nervous system metastases. Journal of neuro-oncology, 2006, Volume: 78, Issue:3 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Central Nervous System Neoplasms; Dose-Response Relationship, Drug; Female; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasms, Unknown Primary; Retrospective Studies; Survival Analysis; Treatment Outcome	2006
A phase II trial of biochemical modulation using N-phosphonacetyl-L-aspartate, high-dose methotrexate, high-dose 5-fluorouracil, and leucovorin in patients with adenocarcinoma of unknown primary site. Cancer, 1992, Oct-01, Volume: 70, Issue:7 Topics: Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Drug Evaluation; Female; Fluorouracil; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Neoplasms, Unknown Primary; Phosphonoacetic Acid; Phosphoribosyl Pyrophosphate; Uridine Triphosphate	1992

Article

Year

Systemic high-dose intravenous methotrexate for central nervous system metastases.

Journal of neuro-oncology, 2006, Volume: 78, Issue:3

Topics: Adult; Aged; Antimetabolites, Antineoplastic; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Central Nervous System Neoplasms; Dose-Response Relationship, Drug; Female; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasms, Unknown Primary; Retrospective Studies; Survival Analysis; Treatment Outcome

2006

A phase II trial of biochemical modulation using N-phosphonacetyl-L-aspartate, high-dose methotrexate, high-dose 5-fluorouracil, and leucovorin in patients with adenocarcinoma of unknown primary site.

Cancer, 1992, Oct-01, Volume: 70, Issue:7

Topics: Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Drug Evaluation; Female; Fluorouracil; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Neoplasms, Unknown Primary; Phosphonoacetic Acid; Phosphoribosyl Pyrophosphate; Uridine Triphosphate

1992

Other Studies

4 other study(ies) available for methotrexate and Neoplasm Metastasis, Unknown Primary

Article	Year
Gestational choriocarcinoma with renal and pulmonary metastases lacking a primary uterine origin. Taiwanese journal of obstetrics & gynecology, 2016, Volume: 55, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Hematuria; Humans; Kidney Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Methotrexate; Neoplasms, Unknown Primary; Pregnancy; Vincristine	2016
Methotrexate-associated lymphoproliferative disorder presenting as disseminated malignancy. Rheumatology (Oxford, England), 2011, Volume: 50, Issue:10 Topics: Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Diagnosis, Differential; Humans; Lymphoproliferative Disorders; Male; Methotrexate; Neoplasms, Unknown Primary; Pleural Effusion; Withholding Treatment	2011
Phase II trial of methotrexate-FAM (m-FAM) in adenocarcinoma of unknown primary. European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Evaluation; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Neoplasms, Unknown Primary	1989
Combination chemotherapy in the treatment of adenocarcinoma of unknown primary origin. Cancer treatment reports, 1987, Volume: 71, Issue:6 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Neoplasms, Unknown Primary; Vincristine	1987

chemdatabank.com